Company intelligence / Profile preview
Constant Therapeutics LLC
Boston, Massachusetts, United Statesconstanttherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Constant Therapeutics LLC develops peptide and small molecule drugs targeting the alternative renin angiotensin system. Its lead candidate TXA127 entered a phase 2 trial in March 2024 for Duchenne Muscular Dystrophy-associated cardiomyopathy. The company also pursues treatments for ischemic stroke recovery and has additional preclinical programs in metabolic and rare diseases. The company’s approach centers on activating the Mas/MrgD receptors to counteract classical RAS effects implicated in cardiovascular and metabolic disorders. Early clinical results are pending from ongoing studies.[1][5]
- Therapeutic areas
- CardiovascularNeurologyMetabolic Disorders
- Modalities
- Peptides (notably synthetic peptides)Small molecules[1][6]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborations with Columbia University noted as sponsor/collaborator on some trials/programs.[6]
Beyond the preview
Go deeper on Constant Therapeutics LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Constant Therapeutics LLC.